Table 2.
The enzyme inhibition percentage of SLE and UAE selected extracts and positive controls in LOX, lipase, and α-amylase enzymes at different concentrations.
| Sample Concentration, mg/mL | LOX Inhibition, % |
Lipase Inhibition, % |
α-Amylase Inhibition, % |
|
|---|---|---|---|---|
| SLE | 1 | 50.87 ± 0.84 a | 25.35 ± 0.35 a | 58.58 ± 2.09 a |
| 0.5 | 49.52 ± 0.35 d | 23.31 ± 1.22 c | 56.73 ± 1.36 bc | |
| 0.1 | 46.59 ± 1.81 g | 22.29 ± 093 e | 47.51 ± 1.22 d | |
| UAE | 1 | 53.64 ± 0.45 b | 26.25 ± 1.04 a | 58.02 ± 1.01 a |
| 0.5 | 52.95 ± 0.75 e | 25.34 ± 0.68 c | 54.26 ± 1.57 c | |
| 0.1 | 49.13 ± 3.38 g | 24.42 ± 1.72 e | 48.50 ± 2.89 d | |
| Quercetin | 1 | 84.98 ± 3.28 c | - | - |
| 0.5 | 79.37 ± 0.60 f | - | - | |
| 0.1 | 77.32 ± 1.20 h | - | - | |
| Orlistat | 1 | - | 34.70 ± 2.59 b | - |
| 0.5 | - | 32.19 ± 0.68 d | - | |
| 0.1 | - | 30.82 ± 0.68 f | - | |
| Metformin hydrochloride | 1 | - | - | 60.68 ± 0.83 a |
| 0.5 | - | - | 58.91 ± 1.57 b | |
| 0.1 | - | - | 56.36 ± 1.01 e | |
Values from a column for a similar concentration that share a letter are not significantly different (p > 0.05). Measurements are expressed as mean ± SD of triplicates. SLE—solid/liquid conventional extraction; UAE—ultrasound-assisted extraction; LOX—lipoxygenase.